Abbott Laboratories (ABT) News

News for Abbott Laboratories (ABT)

Sector News | Topic News

After Hours: $ 55.0614

-0.0486 (-0.09%)

Volume: 159.12 k

5:19 PM EST Feb 10, 2012

Thu, Feb 09, 2012

9:00 AM

A Forward Look, the Year Ahead - Featured Research on Acorda Therapeutics Inc and Abbott Laboratories - Marketwire

Wed, Feb 08, 2012

9:00 AM

Abbott Creates New Similac SimplySmart(tm) Baby Bottle with Innovative Features - PR Newswire

Wed, Feb 01, 2012

8:30 AM

Abbott to Present at Leerink Swann 2012 Global Healthcare Conference - PR Newswire

Mon, Jan 30, 2012

6:05 AM

DNDi and Abbott Expand Partnership to Boost Innovation for Neglected Tropical Diseases - PR Newswire

6:05 AM

DNDi and Abbott Expand Partnership to Boost Innovation for Neglected Tropical Diseases - PR Newswire

Wed, Jan 25, 2012

7:46 AM

Abbott Reports Double-Digit Ongoing Earnings-Per-Share Growth in Fourth Quarter and Full-Year 2011 - PR Newswire

7:46 AM

Abbott Reports Double-Digit Ongoing Earnings-Per-Share Growth in Fourth Quarter and Full-Year 2011 - PR Newswire

Wed, Jan 18, 2012

8:30 AM

Abbott's STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories - PR Newswire

Wed, Jan 04, 2012

9:00 AM

Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2011 Earnings - PR Newswire

Thu, Dec 22, 2011

9:00 AM

Abbott Initiates Clinical Trial to Study Drug Eluting Bioresorbable Therapy for Treatment of Peripheral Artery Disease - PR Newswire

9:00 AM

Abbott Initiates Clinical Trial to Study Drug Eluting Bioresorbable Therapy for Treatment of Peripheral Artery Disease - PR Newswire

Mon, Dec 19, 2011

11:20 AM

Abbott and University of Illinois Establish Center for Nutrition, Learning and Memory - PR Newswire

11:12 AM

Abbott and University of Illinois Establish Center for Nutrition, Learning and Memory - PR Newswire

Thu, Dec 15, 2011

11:40 AM

Abbott to Present at J.P. Morgan Healthcare Conference - PR Newswire

Mon, Dec 12, 2011

6:00 AM

Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Next-Generation Antioxidant Inflammation Modulators - PR Newswire

6:00 AM

Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Next-Generation Antioxidant Inflammation Modulators - PR Newswire

Fri, Dec 09, 2011

12:03 PM

Abbott Declares 352nd Consecutive Quarterly Dividend - PR Newswire

11:55 AM

Abbott Declares 352nd Consecutive Quarterly Dividend - PR Newswire

Thu, Dec 08, 2011

9:30 AM

Abbott Initiates Clinical Trial to Evaluate the Absorb(tm) Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent - PR Newswire

9:30 AM

Abbott Initiates Clinical Trial to Evaluate the Absorb(tm) Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent - PR Newswire

Fri, Dec 02, 2011

12:47 PM

The Law Firm of Levi & Korsinsky Launches an Investigation Into Possible Breaches of Fiduciary Duties and Unjust Enrichment by the Board of Directors of Abbott Laboratories, Inc. - PR Newswire

Thu, Dec 01, 2011

9:01 AM

Direction of Market Influences - Report Highlights Abbott Laboratories and Novartis AG (ADR) - Marketwire

Wed, Nov 30, 2011

4:30 PM

Law Offices of Howard G. Smith Announces Investigation of Abbott Laboratories - Business Wire

9:00 AM

Abbott Receives FDA Clearance for New Test to Detect Vitamin D Levels - PR Newswire

Mon, Nov 28, 2011

9:45 AM

Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen - PR Newswire

First

1 2 3 4 5

Last